NDC 50242-0227-01

Omalizumab 300 mg syringe at The Trustees of the University of Pennsylvania D/B/A The Hospital of the University of Pennsylvania

AI-generated description

How this description was generated

Hospitals report these codes with terse, inconsistent chargemaster text. This plain-English title was written by an AI model from that text and has not been reviewed by a person, so it can be wrong. The prices on this page come straight from hospital filings and do not depend on it.

Model: claude-haiku-5-5
Provider: anthropic
API: message_batches
Reasoning effort: low
Max output tokens: 4096
Prompt version (hash): 444523875572
Generated: October 20, 2026

Original text from hospital filings

OMALIZUMAB 300 MG 2 ML SC SOSY

Philadelphia, PA

See all hospitals reporting NDC 50242-0227-01 →

Pricing by billing methodology

Price type

How this price compares nationally

The Trustees of the University of Pennsylvania D/B/A The Hospital of the University of Pennsylvania’s median price of $3.7k is 3176% above the median hospital's median price ($113), higher than 65% of the 199 hospitals reporting NDC 50242-0227-01. The highlighted bar is where this hospital falls; shaded is the middle 50% of hospitals.

Last updated: Feb 10, 2026

Compare to other hospitals

See Omalizumab 300 mg syringe pricing across every hospital in the network reporting it, or ask Claude or any MCP client directly — see how to connect.